Teflubenzuron
Effects reported:
Genetics
Mortality
Biochemistry
← Scroll →
ⓘ Table glossary
Table glossary
ReferencePubMed ID of research paper
Experimental TypeIn vivo or in vitro
Cell / TissueIf in vitro, cells derived from aquaculture-relevant species
Cell / TissueIf in vitro, tissues obtained from aquaculture-relevant species
Cell / TissueIf in vivo, left blank
Test OrganismAquaculture-relevant species tested for toxic effect
LifestageLifestage of the test organism if mentioned in the reference
AdministrationRoute by which the chemical enters the test organism or treatment method
Administered dose rangeDifferent doses of chemicals tested in this study
Significant dose rangeSignificant result(s) at specific doses
Trend
Direction of effect over time
Measurement
Parameter used to quantify the effect
Effect
Overall observed biological outcome or toxicological effect
| Reference | Experiment type | Cell / tissue | Test organism | Lifestage | Administration | Administered dose | Significant dose | Trend | Measurement | Effect |
|---|---|---|---|---|---|---|---|---|---|---|
| PMID:28939506 | In vivo | - | Palaemon elegans | - | Diet | 0.15 μg |
0.15 μg |
Decreased | Actin mRNA | Genetics |
| In vivo | - | Palaemon elegans | - | Diet | 0.15 μg |
0.15 μg |
Decreased | CTBS mRNA | Genetics | |
| In vivo | - | Palaemon elegans | - | Diet | 0.15 μg |
0.15 μg |
Decreased | Caspase-3 mRNA | Genetics | |
| In vivo | - | Palaemon elegans | - | Diet | 0.15 μg |
0.15 μg |
Decreased | HSP70 mRNA | Genetics | |
| In vivo | - | Palaemon elegans | - | Diet | 0.15 μg |
0.15 μg |
Decreased | Heat shock protein 40 mRNA | Genetics | |
| In vivo | - | Palaemon elegans | - | Diet | 0.15 μg |
0.15 μg |
Decreased | L-lactate dehydrogenase mRNA | Genetics | |
| In vivo | - | Palaemon elegans | - | Diet | 0.15 μg |
0.15 μg |
Decreased | Survival | Mortality | |
| In vivo | - | Palaemon elegans | - | Diet | 0.15 μg |
0.15 μg |
Decreased | Tuba mRNA | Genetics | |
| In vivo | - | Palaemon elegans | - | Diet | 0.15 μg |
0.15 μg |
Increased | Cherax quadricarinatus gastrolith protein (GAP65) mRNA | Genetics | |
| In vivo | - | Palaemon elegans | - | Diet | 0.15 μg |
0.15 μg |
Increased | Crustacean hyperglycemic hormone (CHH) mRNA | Genetics | |
| In vivo | - | Palaemon elegans | - | Diet | 0.15 μg |
0.15 μg |
Increased | Cyp6a18 mRNA | Genetics | |
| PMID:30345541 | In vivo | - | Pandalus montagui | - | Feed | 0.01-0.1 μg/g |
0.1 μg/g |
Decreased | Glutathione peroxidase mRNA | Genetics |
| In vivo | - | Pandalus montagui | - | Feed | 0.1 μg/g |
0.1 μg/g |
Decreased | Protein carbonylation | Biochemistry | |
| In vivo | - | Pandalus montagui | - | Feed | 0.01 μg/g |
0.01 μg/g |
Decreased | Superoxide dismutase 1 mRNA | Genetics |
Glossary
×
ReferencePubMed ID of research paper
Experimental TypeIn vivo or in vitro
Cell / TissueIf in vitro, cells derived from aquaculture-relevant species
Cell / TissueIf in vitro, tissues obtained from aquaculture-relevant species
Cell / TissueIf in vivo, left blank
Test OrganismAquaculture-relevant species tested for toxic effect
LifestageLifestage of the test organism if mentioned in the reference
AdministrationRoute by which the chemical enters the test organism or treatment method
Administered dose rangeDifferent doses of chemicals tested in this study
Significant dose rangeSignificant result(s) at specific doses
Trend
Direction of effect over time
Measurement
Parameter used to quantify the effect
Effect
Overall observed biological outcome or toxicological effect
DISCLAIMER
ReCAnt is a database of chemicals used in aquaculture and their ecotoxic effects, compiled from published literature. The authors are not liable for any inaccuracies or omissions of any chemicals in this resource. Importantly, our sole goal to build this resource on chemicals used in aquaculture is to enable future basic research on this topic, and it does not necessarily reflect the views or objectives of our employers or funders.